Science
FDA Probes Tumour Risk Linked to Novartis Gene Therapy Zolgensma
The FDA is investigating a serious tumour risk linked to Novartis gene therapy Zolgensma after two children's tumours showed evidence…
The FDA is investigating a serious tumour risk linked to Novartis gene therapy Zolgensma after two children's tumours showed evidence…